2 February 2016. A review of an FDA advisory committee on cancer drugs finds nearly one-third of speakers at its meetings receive financial support from companies making the drugs under review. The analysis by Vinay Prasad at Oregon Health and Science University and Matthew Abola, a medical student at Case Western . . . → Read More: Many FDA Advisory Speakers Found with Industry Funding
You must be logged in to post a comment.